Previous studies have shown that two patients with homozygous pathogenic variants in MAPRE2 had severe neurological dysfunction, accompanied by intellectual impairment and seizures, whereas there was no neurological dysfunction in the patients with pathogenic TUBB variants. Here, MAPRE2 is linked to Cognitive impairment.